Sunday, October 11, 2026

Lumen Technologies Stock Over 28% Down In The Last 21 Sessions

ViaNews Editorial Team

February 16, 2023

Lumen Technologies Stock Over 28% Down In The Last 21 Sessions

(VIANEWS) - Shares of Lumen Technologies (NYSE: LUMN) dropped by a staggering 28.92% in 21 sessions from $5.36 to $3.81 at 11:23 EST on Thursday, after four sequential sessions in a row of losses. NYSE is sliding 0.58% to $15,922.85, after two successive sessions in a row of losses.

Lumen Technologies's last close was $3.91, 74.12% below its 52-week high of $15.11.

About Lumen Technologies

Lumen Technologies, Inc., a facilities-based technology and communications company, provides various integrated products and services under the Lumen, Quantum Fiber, and CenturyLink brands to business and residential customers in the United States and internationally. The company operates in two segments, Business and Mass Markets. It offers compute and application services, such as cloud services, IT solutions, unified communication and collaboration solutions, colocation and data center services, content delivery services, and managed security services; and IP and data services, including VPN data network, Ethernet, internet protocol (IP), and voice over internet protocol. The company also provides fiber infrastructure services comprising high bandwidth optical wavelength networks; and unlit optical fiber and related professional services. In addition, it offers voice and other services, including private line services, a direct circuit or channel specifically dedicated for connecting two or more organizational sites; a portfolio of traditional time division multiplexing voice services; and synchronous optical network-based Ethernet, legacy data hosting services, and conferencing services. As of December 31, 2021, the company served approximately 4.5 million broadband subscribers. The company was formerly known as CenturyLink, Inc. and changed its name to Lumen Technologies, Inc. in September 2020. Lumen Technologies, Inc. was incorporated in 1968 and is headquartered in Monroe, Louisiana.

Earnings Per Share

As for profitability, Lumen Technologies has a trailing twelve months EPS of $-0.709.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.68%.

Volatility

Lumen Technologies's last week, last month's, and last quarter's current intraday variation average was a negative 7.09%, a negative 2.16%, and a positive 2.84%.

Lumen Technologies's highest amplitude of average volatility was 8.54% (last week), 4.32% (last month), and 2.84% (last quarter).

Moving Average

Lumen Technologies's worth is way below its 50-day moving average of $11.33 and way below its 200-day moving average of $11.96.

Sales Growth

Lumen Technologies's sales growth is negative 6.8% for the present quarter and negative 8.1% for the next.

More news about Lumen Technologies (LUMN).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic AI Rewires Enterprise Software: Platform Incumbents, Governance, and a Funded Startup Wave
Enterprise software is being rebuilt around autonomous AI agents. Incumbents and large platforms (SAP with its Autonomous Suite and Joule, Zeta with AthenaOS/AIM/Athena MCP, Meta with its new Enterprise Platform) are racing to own the agent layer. Meanwhile, seed and Series A money flows to finance-office and vertical startups (Dextr, Latitude, Dentira, Light), and consolidation continues through acquisitions (Tiny–Oso Cloud, Harvey–Guardrails AI). Investor commentary stresses that AI is better at disrupting around the edges of systems of record than at replacing them, that it should not be trusted with finance calculations, and that governance must be enforced by the system rather than left to agents.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,369 source documents archived
Query this data → isubstrate.com